View in EDS HTML Full Text PDF Full Text

Human iPSC-derived NK cells armed with CCL19, CCR2B, high-affinity CD16, IL-15, and NKG2D complex enhance anti-solid tumor activity.

Saved in:
Bibliographic Details
Title: Human iPSC-derived NK cells armed with CCL19, CCR2B, high-affinity CD16, IL-15, and NKG2D complex enhance anti-solid tumor activity.
Authors: Fukutani, Yuma1 (AUTHOR), Kurachi, Kenji1 (AUTHOR), Torisawa, Yu-suke1 (AUTHOR), Miyata, Kotoko1 (AUTHOR), Hayashi, Makoto1 (AUTHOR), Sasaki, Kaoru1 (AUTHOR), Saitoh, Kodai1 (AUTHOR), Watanabe, Sono1 (AUTHOR), Hasegawa, Yudai1 (AUTHOR), Naritomi, Yoichi1 (AUTHOR), Igarashi, Yuka1 (AUTHOR), Goto, Kumiko1 (AUTHOR), Sato, Yuka1 (AUTHOR), Uesugi, Noriko1 (AUTHOR), Murai, Hidetaka1 (AUTHOR), Sakurai, Tetsuya1 (AUTHOR), Ozaki, Toru1 (AUTHOR), Tsuneyoshi, Norihiro1 (AUTHOR), Yamada, Masashi1 (AUTHOR), Takeno, Yuriko1 (AUTHOR)
Source: Stem Cell Research & Therapy. 7/15/2025, Vol. 16 Issue 1, p1-24. 24p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17576512
DOI:10.1186/s13287-025-04461-9